Today, Scapa Healthcare announces the launch of its new perforation capability for Scapa Soft-Pro® Silicone Gel adhesives. The new capability allows Scapa Healthcare to offer its strategic business partners an expansive range of skin friendly turn-key solutions for the advanced wound care market.
Scapa Soft-Pro® Silicone Gel is a low trauma adhesive that allows for easy application, removal and reapplication on the same area. Its gentle skin friendly properties are ideal for users with fragile and sensitive skin. The new perforation capability allows Scapa Healthcare to meet dressing challenges for exudate management in the advanced wound care market.
Gentle enough to be applied directly on an open chronic or acute wound, perforated Scapa Soft-Pro® Silicone Gel delivers enhanced breathability and improved wound management. The perforations allow for transmission of fluid and wound exudate into the absorbent layer of the dressing, better managing wound surface moisture and risk of maceration. Scapa Soft-Pro® Silicone Gel is now available in a 2.8mm perforated format. Material widths range from 90mm to 270mm. The perforated silicone gel layer is ideal for use with absorbable components in a layered dressing construction.
The new capability allows Scapa Healthcare to offer a more comprehensive range of advanced wound care dressings that support patient comfort and recovery time. Further information on the perforation capability for Scapa Soft-Pro® Silicone Gel can be found at www.scapahealthcare.com/capabilities/adhesives.
About Scapa Group, plc
Scapa is a leading worldwide manufacturer of bonding solutions and adhesive components for applications in the industrial, automotive, cable, construction, graphics, retail, electronics and healthcare markets. They help customers create better products by providing customized adhesive solutions and components for the broad range of markets that they do business in. They design their offering around the requirements of global OEMs, distributors and consumers.